Welcome to MutualFunds.com. Please help us personalize your experience.
Your personalized experience is almost ready.
Check your email and confirm your subscription to complete your personalized experience.
Thank you for your submission, we hope you enjoy your experience
The firm has raised its 2015 EPS estimates from $2.07 to $2.08. FY2016 EPS estimates were increased from $2.21 to $2.30.
The analyst commented: “We expect PFE shares to significantly appreciate over the next 1-2 years based on a better than expected launch of Ibrance, greater appreciation of the durable growth on offer in GEP, further accretive and potentially tax-driven M&A, and the separation of GEP by 2017 at a minimum from the rest of the business.”
The stock has grown at a steady rate over the last few years and has a dividend yield of about 3.2%. Pfizer stock is perhaps most ideal for income-focused investors that are planning on holding the stock over the long-haul.
|VTSMX||Vanguard Total Stock Mkt Idx||1.79%|
|VFINX||Vanguard 500 Index||1.15%|
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Subscribe to receive FREE updates, insigns, and more, straight to your inbox